{"pmid":32375855,"pmcid":"PMC7202791","title":"Ethics guidelines on COVID-19 triage-an emerging international consensus.","text":["Ethics guidelines on COVID-19 triage-an emerging international consensus.","Crit Care","Joebges, Susanne","Biller-Andorno, Nikola","32375855"],"journal":"Crit Care","authors":["Joebges, Susanne","Biller-Andorno, Nikola"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32375855","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1186/s13054-020-02927-1","keywords":["covid-19","ethics","pandemic","triage"],"weight":0,"_version_":1666596532362674178,"score":9.490897,"similar":[{"pmid":32405671,"title":"Ethical triage during the COVID-19 pandemic: a toolkit for neurosurgical resource allocation.","text":["Ethical triage during the COVID-19 pandemic: a toolkit for neurosurgical resource allocation.","BACKGROUND: The COVID-19 pandemic confronts healthcare workers, including neurosurgeons, with difficult choices regarding which patients to treat. METHODS: In order to assist ethical triage, this article gives an overview of the main considerations and ethical principles relevant when allocating resources in times of scarcity. RESULTS: We discuss a framework employing four principles: prioritizing the worst off, maximizing benefits, treating patients equally, and promoting instrumental value. We furthermore discuss the role of age and comorbidity in triage and highlight some principles that may seem intuitive but should not form a basis for triage. CONCLUSIONS: This overview is presented on behalf of the European Association of Neurosurgical Societies and can be used as a toolkit for neurosurgeons faced with ethical dilemmas when triaging patients in times of scarcity.","Acta Neurochir (Wien)","Hulsbergen, Alexander F C","Eijkholt, Marleen M","Balak, Naci","Brennum, Jannick","Bolger, Ciaran","Bohrer, Anna-Margarete","Feldman, Zeev","Holsgrove, Daniel","Kitchen, Neil","Mathiesen, Tiit I","Moojen, Wouter A","Sampron, Nicolas","Sames, Martin","Sandvik, Ulrika","Tisell, Magnus","Broekman, Marike L D","32405671"],"abstract":["BACKGROUND: The COVID-19 pandemic confronts healthcare workers, including neurosurgeons, with difficult choices regarding which patients to treat. METHODS: In order to assist ethical triage, this article gives an overview of the main considerations and ethical principles relevant when allocating resources in times of scarcity. RESULTS: We discuss a framework employing four principles: prioritizing the worst off, maximizing benefits, treating patients equally, and promoting instrumental value. We furthermore discuss the role of age and comorbidity in triage and highlight some principles that may seem intuitive but should not form a basis for triage. CONCLUSIONS: This overview is presented on behalf of the European Association of Neurosurgical Societies and can be used as a toolkit for neurosurgeons faced with ethical dilemmas when triaging patients in times of scarcity."],"journal":"Acta Neurochir (Wien)","authors":["Hulsbergen, Alexander F C","Eijkholt, Marleen M","Balak, Naci","Brennum, Jannick","Bolger, Ciaran","Bohrer, Anna-Margarete","Feldman, Zeev","Holsgrove, Daniel","Kitchen, Neil","Mathiesen, Tiit I","Moojen, Wouter A","Sampron, Nicolas","Sames, Martin","Sandvik, Ulrika","Tisell, Magnus","Broekman, Marike L D"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32405671","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1007/s00701-020-04375-w","keywords":["covid-19","ethics","neurosurgery","sars-cov-2","triage"],"weight":0,"_version_":1666802845550116864,"score":69.88632},{"pmid":32341719,"pmcid":"PMC7182506","title":"Covid-19 pandemic by the \"real-time\" monitoring: the Tunisian case and lessons for global epidemics in the context of 3PM strategies.","text":["Covid-19 pandemic by the \"real-time\" monitoring: the Tunisian case and lessons for global epidemics in the context of 3PM strategies.","Covid-19 is neither the first nor the last viral epidemic which societies around the world are, were and will be affected by. Which lessons should be taken from the current pandemic situation? The Covid-19 disease is still not well characterised, and many research teams all over the world are working on prediction of the epidemic scenario, protective measures to populations and sub-populations, therapeutic and vaccination issues, amongst others. Contextually, countries with currently low numbers of Covid-19-infected individuals such as Tunisia are intended to take lessons from those countries which already reached the exponential phase of the infection distribution as well as from those which have the exponential phase behind them and record a minor number of new cases such as China. To this end, in Tunisia, the pandemic wave has started with a significant delay compared with Europe, the main economic partner of the country. In this paper, we do analyse the current pandemic situation in this country by studying the infection evolution and considering potential protective strategies to prevent a pandemic scenario. The model is predictive based on a large number of undetected Covid-19 cases that is particularly true for some country regions such as Sfax. Infection distribution and mortality rate analysis demonstrate a highly heterogeneous picture over the country. Qualitative and quantitative comparative analysis leads to a conclusion that the reliable \"real-time\" monitoring based on the randomised laboratory tests is the optimal predictive strategy to create the most effective evidence-based preventive measures. In contrast, lack of tests may lead to incorrect political decisions causing either unnecessary over-protection of the population that is risky for a long-term economic recession, or under-protection of the population leading to a post-containment pandemic rebound. Recommendations are provided in the context of advanced predictive, preventive and personalised (3P) medical approach.","EPMA J","Chaari, Lotfi","Golubnitschaja, Olga","32341719"],"abstract":["Covid-19 is neither the first nor the last viral epidemic which societies around the world are, were and will be affected by. Which lessons should be taken from the current pandemic situation? The Covid-19 disease is still not well characterised, and many research teams all over the world are working on prediction of the epidemic scenario, protective measures to populations and sub-populations, therapeutic and vaccination issues, amongst others. Contextually, countries with currently low numbers of Covid-19-infected individuals such as Tunisia are intended to take lessons from those countries which already reached the exponential phase of the infection distribution as well as from those which have the exponential phase behind them and record a minor number of new cases such as China. To this end, in Tunisia, the pandemic wave has started with a significant delay compared with Europe, the main economic partner of the country. In this paper, we do analyse the current pandemic situation in this country by studying the infection evolution and considering potential protective strategies to prevent a pandemic scenario. The model is predictive based on a large number of undetected Covid-19 cases that is particularly true for some country regions such as Sfax. Infection distribution and mortality rate analysis demonstrate a highly heterogeneous picture over the country. Qualitative and quantitative comparative analysis leads to a conclusion that the reliable \"real-time\" monitoring based on the randomised laboratory tests is the optimal predictive strategy to create the most effective evidence-based preventive measures. In contrast, lack of tests may lead to incorrect political decisions causing either unnecessary over-protection of the population that is risky for a long-term economic recession, or under-protection of the population leading to a post-containment pandemic rebound. Recommendations are provided in the context of advanced predictive, preventive and personalised (3P) medical approach."],"journal":"EPMA J","authors":["Chaari, Lotfi","Golubnitschaja, Olga"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32341719","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1007/s13167-020-00207-0","keywords":["anti-body","anti-gene","bottle-neck","comorbidities","covid-19","depression","economy","epidemics","ethics","home isolation","individual outcomes","infection","laboratory medicine","multi-professional expertise","pandemic","policymaking","population screening","predictive preventive personalised (3p) medicine","psychotic attitude","related mortality","sars-cov-2","salami-tactic","strategy","suicide","suppressed immune defence","targeted protective measures","test","titanic","triage","violence","\"real-time\" monitoring"],"locations":["China","Tunisia","Tunisian"],"countries":["Tunisia","China"],"countries_codes":["TUN|Tunisia","CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1666138495074172929,"score":60.562466},{"pmid":32426441,"pmcid":"PMC7230138","title":"Prioritisation of ICU treatments for critically ill patients in a COVID-19 pandemic with scarce resources.","text":["Prioritisation of ICU treatments for critically ill patients in a COVID-19 pandemic with scarce resources.","BACKGROUND: Relying on capacity increases and patient transfers to deal with the huge and continuous inflow of COVID-19 critically ill patients is a strategy limited by finite human and logistical resources. RATIONALE: Prioritising both critical care initiation and continuation is paramount to save the greatest number of lives. It enables to allocate scarce resources in priority to those with the highest probability of benefiting from them. It is fully ethical provided it relies on objective and widely shared criteria, thus preventing arbitrary decisions and guaranteeing equity. Prioritisation seeks to fairly allocate treatments, maximise saved lives, gain indirect life benefits from prioritising exposed healthcare and similar workers, give priority to those most penalised as a last resort, and apply similar prioritisation schemes to all patients. PRIORITISATION STRATEGY: Prioritisation schemes and their criteria are adjusted to the level of resource scarcity: strain (level A) or saturation (level B). Prioritisation yields a four level priority for initiation or continuation of critical care: P1 - high priority, P2 - intermediate priority, P3 - not needed, P4 - not appropriate. Prioritisation schemes take into account the patient's wishes, clinical frailty, pre-existing chronic condition, along with severity and evolution of acute condition. Initial priority level must be reassessed, at least after 48 h once missing decision elements are available, at the typical turning point in the disease's natural history (ICU days 7 to 10 for COVID-19), and each time resource scarcity levels change. For treatments to be withheld or withdrawn, a collegial decision-making process and information of patient and/or next of kin are paramount. PERSPECTIVE: Prioritisation strategy is bound to evolve with new knowledge and with changes within the epidemiological situation.","Anaesth Crit Care Pain Med","Leclerc, Thomas","Donat, Nicolas","Donat, Alexis","Pasquier, Pierre","Nicolas, Libert","Schaeffer, Elodie","D'aranda, Erwan","Cotte, Jean","Fontaine, Bruno","Perrigault, Pierre-Francois","Michel, Fabrice","Muller, Laurent","Meaudre, Eric","Veber, Benoit","32426441"],"abstract":["BACKGROUND: Relying on capacity increases and patient transfers to deal with the huge and continuous inflow of COVID-19 critically ill patients is a strategy limited by finite human and logistical resources. RATIONALE: Prioritising both critical care initiation and continuation is paramount to save the greatest number of lives. It enables to allocate scarce resources in priority to those with the highest probability of benefiting from them. It is fully ethical provided it relies on objective and widely shared criteria, thus preventing arbitrary decisions and guaranteeing equity. Prioritisation seeks to fairly allocate treatments, maximise saved lives, gain indirect life benefits from prioritising exposed healthcare and similar workers, give priority to those most penalised as a last resort, and apply similar prioritisation schemes to all patients. PRIORITISATION STRATEGY: Prioritisation schemes and their criteria are adjusted to the level of resource scarcity: strain (level A) or saturation (level B). Prioritisation yields a four level priority for initiation or continuation of critical care: P1 - high priority, P2 - intermediate priority, P3 - not needed, P4 - not appropriate. Prioritisation schemes take into account the patient's wishes, clinical frailty, pre-existing chronic condition, along with severity and evolution of acute condition. Initial priority level must be reassessed, at least after 48 h once missing decision elements are available, at the typical turning point in the disease's natural history (ICU days 7 to 10 for COVID-19), and each time resource scarcity levels change. For treatments to be withheld or withdrawn, a collegial decision-making process and information of patient and/or next of kin are paramount. PERSPECTIVE: Prioritisation strategy is bound to evolve with new knowledge and with changes within the epidemiological situation."],"journal":"Anaesth Crit Care Pain Med","authors":["Leclerc, Thomas","Donat, Nicolas","Donat, Alexis","Pasquier, Pierre","Nicolas, Libert","Schaeffer, Elodie","D'aranda, Erwan","Cotte, Jean","Fontaine, Bruno","Perrigault, Pierre-Francois","Michel, Fabrice","Muller, Laurent","Meaudre, Eric","Veber, Benoit"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32426441","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.accpm.2020.05.008","keywords":["covid-19","critical care","ethics","pandemic","prioritisation","triage"],"topics":["Prevention"],"weight":1,"_version_":1667252837952782337,"score":60.562466},{"pmid":32395064,"pmcid":"PMC7212248","title":"To Do or Not to Do?-A Review of Cancer Surgery Triage Guidelines in COVID-19 Pandemic.","text":["To Do or Not to Do?-A Review of Cancer Surgery Triage Guidelines in COVID-19 Pandemic.","COVID-19 pandemic has emerged as a global health emergency involving more than 200 countries so far. The number of affected population is on rising, so is the mortality. This crisis has overwhelmed the healthcare infrastructures in many affected countries. Due to overall rising cancer incidence and specific concerns, a cohort of cancer patients forms a distinct subset of the population in whom a correct and timely treatment has a huge impact on the outcome. During this period, oncology care is definitely affected owing to many factors like lockdowns, reduced beds and deferral of elective cases to halt the spread of the pandemic. Surgery remains the best line of defence in many solid organ tumours especially in early stage and is potentially curative. China, the source of this pandemic, has taken more than 3 months to enter the post transitional phase of this pandemic. Deferring cancer surgeries for this long period may have a direct impact on the long-term outcomes of cancer patients. Many surgical oncology associations across the globe have come up with triage guidelines for surgical care of cancer patients; however, these are based on expert opinion rather than actual data. Herein, we intend to review these guidelines with respect to the risk of disease progression in cancer patients. In the absence of actual data on cancer surgery care during this pandemic, clinical decisions should be based on careful consideration of disease-related and patient-related factors. While some of the cancer surgeries can be safely delayed for some time, how long we can delay surgeries safely cannot be answered/ explained by any means. Thorough evaluation and discussion by an expert and experienced multidisciplinary team appears to be the most effective way forward.","Indian J Surg Oncol","Shinde, Rajesh S","Naik, Mekhala D","Shinde, Shital R","Bhandare, Manish S","Chaudhari, Vikram A","Shrikhande, Shailesh V","Dcruz, Anil K","32395064"],"abstract":["COVID-19 pandemic has emerged as a global health emergency involving more than 200 countries so far. The number of affected population is on rising, so is the mortality. This crisis has overwhelmed the healthcare infrastructures in many affected countries. Due to overall rising cancer incidence and specific concerns, a cohort of cancer patients forms a distinct subset of the population in whom a correct and timely treatment has a huge impact on the outcome. During this period, oncology care is definitely affected owing to many factors like lockdowns, reduced beds and deferral of elective cases to halt the spread of the pandemic. Surgery remains the best line of defence in many solid organ tumours especially in early stage and is potentially curative. China, the source of this pandemic, has taken more than 3 months to enter the post transitional phase of this pandemic. Deferring cancer surgeries for this long period may have a direct impact on the long-term outcomes of cancer patients. Many surgical oncology associations across the globe have come up with triage guidelines for surgical care of cancer patients; however, these are based on expert opinion rather than actual data. Herein, we intend to review these guidelines with respect to the risk of disease progression in cancer patients. In the absence of actual data on cancer surgery care during this pandemic, clinical decisions should be based on careful consideration of disease-related and patient-related factors. While some of the cancer surgeries can be safely delayed for some time, how long we can delay surgeries safely cannot be answered/ explained by any means. Thorough evaluation and discussion by an expert and experienced multidisciplinary team appears to be the most effective way forward."],"journal":"Indian J Surg Oncol","authors":["Shinde, Rajesh S","Naik, Mekhala D","Shinde, Shital R","Bhandare, Manish S","Chaudhari, Vikram A","Shrikhande, Shailesh V","Dcruz, Anil K"],"date":"2020-05-13T11:00:00Z","year":2020,"_id":"32395064","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1007/s13193-020-01086-7","keywords":["cancer","guidelines","surgery","triage"],"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1666627828072841216,"score":58.221783},{"pmid":32426220,"pmcid":"PMC7229740","title":"Triage of Patients with Venous and Lymphatic Diseases during the COVID-19 pandemic- the Venous and Lymphatic Triage and Acuity Scale (VELTAS).","text":["Triage of Patients with Venous and Lymphatic Diseases during the COVID-19 pandemic- the Venous and Lymphatic Triage and Acuity Scale (VELTAS).","The coronavirus disease 2019 (COVID-19) global pandemic has resulted in diversion of healthcare resources to the management of patients infected with SARS-CoV-2 virus. Elective interventions and surgical procedures in most countries have been postponed and operating room resources have been diverted to manage the pandemic. The Venous and Lymphatic Triage and Acuity Scale (VELTAS) was developed to provide an international standard to rationalise and harmonise the management of patients with venous and lymphatic disorders or vascular anomalies. Triage urgency was determined based on clinical assessment of urgency with which a patient would require medical treatment or surgical intervention. Clinical conditions were classified into six categories of: 1) Venous thromboembolism (VTE), 2) Chronic Venous Disease (CVD), 3) Vascular anomalies, 4) Venous trauma 5) Venous compression and 6) Lymphatic disease. Triage urgency was categorised into four groups and individual conditions were allocated to each class of triage. These included 1) Medical Emergencies (requiring immediate attendance), example massive pulmonary embolism; 2) Urgent (to be seen as soon as possible), example deep vein thrombosis ; 3) Semi-urgent (to be attended to within 30-90 days), example highly symptomatic CVD, and 4) Discretionary/Non-urgent- (to be seen within 6-12 months), example chronic lymphoedema. VELTAS aims to standardise the triage of patients with venous and lymphatic disease or vascular anomalies by providing an international consensus-based classification of clinical categories and triage urgency. The scale may be used during pandemics such as the current COVID-19 crisis but may also be used as a general framework to classify urgency of the listed conditions.","J Vasc Surg Venous Lymphat Disord","Parsi, Kurosh","van Rij, Andre M","Meissner, Mark H","Davies, Alun H","De Maeseneer, Marianne","Gloviczki, Peter","Benson, Stephen","Bottini, Oscar","Canata, Victor Manuel","Dinnen, Paul","Gasparis, Antonios","Gianesini, Sergio","Huber, David","Jenkins, David","Lal, Brajesh K","Kabnick, Lowell","Lim, Adrian","Marston, William","Granados, Alberto Martinez","Morrison, Nick","Nicolaides, Andrew","Paraskevas, Peter","Patel, Malay","Roberts, Stefania","Rogan, Christopher","Schul, Marlin W","Komlos, Pedro","Stirling, Andrew","Thibault, Simon","Varghese, Roy","Welch, Harold J","Wittens, Cees H A","32426220"],"abstract":["The coronavirus disease 2019 (COVID-19) global pandemic has resulted in diversion of healthcare resources to the management of patients infected with SARS-CoV-2 virus. Elective interventions and surgical procedures in most countries have been postponed and operating room resources have been diverted to manage the pandemic. The Venous and Lymphatic Triage and Acuity Scale (VELTAS) was developed to provide an international standard to rationalise and harmonise the management of patients with venous and lymphatic disorders or vascular anomalies. Triage urgency was determined based on clinical assessment of urgency with which a patient would require medical treatment or surgical intervention. Clinical conditions were classified into six categories of: 1) Venous thromboembolism (VTE), 2) Chronic Venous Disease (CVD), 3) Vascular anomalies, 4) Venous trauma 5) Venous compression and 6) Lymphatic disease. Triage urgency was categorised into four groups and individual conditions were allocated to each class of triage. These included 1) Medical Emergencies (requiring immediate attendance), example massive pulmonary embolism; 2) Urgent (to be seen as soon as possible), example deep vein thrombosis ; 3) Semi-urgent (to be attended to within 30-90 days), example highly symptomatic CVD, and 4) Discretionary/Non-urgent- (to be seen within 6-12 months), example chronic lymphoedema. VELTAS aims to standardise the triage of patients with venous and lymphatic disease or vascular anomalies by providing an international consensus-based classification of clinical categories and triage urgency. The scale may be used during pandemics such as the current COVID-19 crisis but may also be used as a general framework to classify urgency of the listed conditions."],"journal":"J Vasc Surg Venous Lymphat Disord","authors":["Parsi, Kurosh","van Rij, Andre M","Meissner, Mark H","Davies, Alun H","De Maeseneer, Marianne","Gloviczki, Peter","Benson, Stephen","Bottini, Oscar","Canata, Victor Manuel","Dinnen, Paul","Gasparis, Antonios","Gianesini, Sergio","Huber, David","Jenkins, David","Lal, Brajesh K","Kabnick, Lowell","Lim, Adrian","Marston, William","Granados, Alberto Martinez","Morrison, Nick","Nicolaides, Andrew","Paraskevas, Peter","Patel, Malay","Roberts, Stefania","Rogan, Christopher","Schul, Marlin W","Komlos, Pedro","Stirling, Andrew","Thibault, Simon","Varghese, Roy","Welch, Harold J","Wittens, Cees H A"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32426220","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.jvsv.2020.05.002","keywords":["covid-19","sars-cov-2","lymphatic","pandemic","triage","vascular","vascular anomalies","vascular malformations","venous"],"topics":["Prevention"],"weight":1,"_version_":1667252837790253057,"score":54.889145}]}